Biochemical and nutritional changes during continuous subcutaneous apomorphine infusion in advanced Parkinson’s disease: findings from an observational cohort
Therapeutic Advances in Neurological Disorders
Published online on May 10, 2026
Abstract
Therapeutic Advances in Neurological Disorders, Volume 19, January-December 2026.
Background:Patients with Parkinson’s disease (PD) receiving device-aided therapies (DATs) frequently experience vitamin B depletion and nutritional challenges. However, the effects of continuous subcutaneous apomorphine infusion (CSAI) on vitamin B status ...
Background:Patients with Parkinson’s disease (PD) receiving device-aided therapies (DATs) frequently experience vitamin B depletion and nutritional challenges. However, the effects of continuous subcutaneous apomorphine infusion (CSAI) on vitamin B status ...